Top Clinical Trials Stories


Comment & Analysis »

GlobalData Healthcare

With Melinta Merger, Cempra Lands on Its Feet Despite Regulatory Struggles

On 9 August, Melinta Therapeutics and Cempra Pharmaceuticals jointly announced a merger agreement that will result in Melinta’s shareholders owning 52% of the new company....

With Melinta Merger, Cempra Lands on Its Feet Despite Regulatory Struggles
GlobalData Healthcare

BMS shifts towards precision medicine

BMS shifts towards precision medicine
GlobalData Healthcare

Dynavax’s Heplisav-B passes key regulatory hurdle with FDA Advisory Committee endorsement

Dynavax’s Heplisav-B passes key regulatory hurdle with FDA Advisory Committee endorsement
GlobalData Healthcare

Tensions Rise as UK Pharma Industry Takes Government to Court

Tensions Rise as UK Pharma Industry Takes Government to Court
GlobalData Healthcare

A vaccine for Lyme disease – second time lucky?

A vaccine for Lyme disease – second time lucky?

Clinical Trials Insights »

Companies »